VP
Insider
Venrock Healthcare Capital Partners III, L.P.
10% ownerVenrock Healthcare Capital Partners III, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in KALV. The largest single filing was $929K of KALV (100,352 sh across 2 lots, as filed), executed Feb 7 2025. The median gap between execution and disclosure was 4 days.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
–
purchases not yet priced
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$929K
shares × price, as filed
Last traded
Feb 11 2025
Filed Feb 11 2025
100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $929K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
KALV
KALV
KALV · 1 buy · 0 sells
1 filing
Recent filings
KALVPURCHASE
KalVista Pharmaceuticals, Inc.
View filing →
$929K100,352 sh across 2 lots
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET